Company News

Nov 03, 2007

Spectral Image, Inc. Receives $5 Million Series A from GBP Capital

Greenwich, CT and Tampa, FL November 3, 2007 -- Spectral Image Inc., a privately held early stage medical device company focused on the development of imaging technology for biomedical use, today announced the completion of a $5 million Series A venture financing with GBP Capital. At th Read More...

Filed Under: Company News

Sep 17, 2007

Lentigen Partners with Thermo Fisher Scientific to Offer Revolutionary SMARTvector shRNA Lentiviral Particles for Gene Silencing

Baltimore, MD, September 17, 2007 Thermo Fisher Scientific Inc., the world leader in serving science, has partnered with Lentigen Corporation, a renowned developer of lentiviral vector gene-delivery systems, to launch Thermo Scientific Dharmacon SMARTvector shRNA Read More...

Filed Under: Company News

Jun 20, 2007

Lentigen Corporation Named Best Life Science Company in 7th Annual Maryland Incubator Company of the Year Awards

Baltimore, MD, June 20, 2007 Lentigen Corporation, a privately held biotechnology company focused on the manufacturing and development of lentiviral vectors, announced today that it has been named Best Life Science Company in the 7th Annual Maryland Incubator C Read More...

Filed Under: Company News

Feb 28, 2007

HyperMed, Inc. Receives $5 Million Series A from Greenwich Biotech Partners

Waltham, MA- February 28, 2007 HyperMed, Inc., the leader in hyperspectral medical imaging, today announced it has secured $5 million in Series A financing from Greenwich Biotech Partners. Proceeds from this financing will be used to market, sell and support HyperMe Read More...

Filed Under: Company News

Feb 28, 2007

HyperMed, Inc. Announces the Addition of Two Directors to its Board

Waltham, MA - February 28, 2007 HyperMed, Inc., the leader in hyperspectral medical imaging, today announced the addition of Douglas Lind, MD and Bruce Ryan, PhD to the HyperMed Board of Directors, joining founders Jenny Fr Read More...

Filed Under: Company News

Jan 25, 2007

Lentigen Corporation and Wave Biotech, LLC Announce Formation of Collaboration

Baltimore, MD and Somerset, NJ January 25, 2007 Lentigen Corporation and Wave Biotech, LLC announced today that they have entered into a collaboration under which Wave Biotech will provide process and equipment expertise for Lentigen’s manufacturing pl Read More...

Filed Under: Company News

Dec 04, 2006

Lentigen Corporation Named Technology Pioneer for 2007 by The World Economic Forum

BALTIMORE, MD, DECEMBER 4, 2006 The World Economic Forum today named Lentigen Corporation one of 47 Technology Pioneers for 2007. A panel of top technology experts appointed by the World Economic Forum made the final selection from 225 ca Read More...

Filed Under: Company News

Nov 30, 2006

Lentigen Corporation Receives Grant From the NIH To Develop a Potential New Therapy For The Treatment of Chronic Lymphocytic Leukemia

Baltimore, MD and Philadelphia, PA November 30, 2006 Lentigen Corporation announced today that it has received National Institute of Health (NIH) Small Business Innovation Research (SBIR) funding to develop an improved and nove Read More...

Filed Under: Company News

Nov 20, 2006

Lentigen Appoints Adam L. Sachs to President, Commercial Operations

Baltimore, Maryland, November 20, 2006 - Lentigen Corporation, a biopharmaceutical company focused on the discovery and development of novel biologics based on its proprietary LentiMaxTM platform, announced today the appointment of Read More...

Filed Under: Company News

Oct 17, 2006

Lentigen Corporation Recieves Grant From NIH to Evaluate the Use of Lentiviral-Engineered T-Cells for Cancer Immunotherapy Directed Against Key Tumor Antigen

Baltimore, MD and Philadelphia, PA October 17, 2006 Lentigen Corporation announced today it has obtained National Institutes of Health (NIH) Small Business Innovation Research (SBIR) Phase I funding to evaluate the novel concep Read More...

Filed Under: Company News

45 results:

<<12345>>